Premium
Commentary on “Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies” by Sievers et al.
Author(s) -
Rissmann Robert,
Zuiker Rob
Publication year - 2021
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.14823
Subject(s) - blinding , medicine , clinical trial , preclinical research , external validity , medical physics , psychology , pathology , social psychology